Form 4: Phreesia Officer Converts Bonus to Stock, Boosts Holdings
Insider Transaction Report
Phreesia's Principal Accounting Officer, Yvonne Hui, elected to convert her first-half fiscal year 2026 cash bonus into 2,388 fully vested Restricted Stock Units.
Summary
- Yvonne Hui, Principal Accounting Officer of Phreesia, Inc. (PHR), acquired 2,388 shares of common stock.
- The acquisition was made on September 11, 2025, through the conversion of a cash bonus into Restricted Stock Units (RSUs).
- These RSUs were fully vested as of the grant date and represent awards for the first half of the fiscal year ending January 31, 2026.
- Hui elected to convert her earned cash bonus into RSUs at a rate representing 115% of the cash bonus amount.
- The number of RSUs granted was based on a per share value of $25.48, which was the closing price of Phreesia's common stock on September 11, 2025.
- Following this transaction, Yvonne Hui beneficially owns 31,578 shares of Phreesia common stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as an executive's decision to convert a cash bonus into company stock, especially at an incentivized rate, typically signals confidence in the company's future prospects and aligns management's interests with shareholders.
Positives
- Increased insider ownership by a key executive, signaling confidence in the company's future performance.
- The election to convert a cash bonus into equity, especially at an incentivized rate (115%), aligns management's interests more closely with shareholders.
Future Outlook
The transaction relates to a bonus earned for the first half of the fiscal year ending January 31, 2026, indicating ongoing executive compensation plans tied to future company performance.
Management Comments
- Represents Restricted Stock Units ('RSUs') that were fully vested as of the grant date.
- These RSUs represent awards received in lieu of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2026 under the Issuer's Senior Executive Cash Incentive Bonus Plan.
- The Reporting Person elected to convert such cash bonus into RSUs representing 115% of the earned cash bonus amount.
- The number of RSUs granted is based on a per share value of $25.48, the closing price of the Issuer's common stock on September 11, 2025.
Industry Context
This transaction reflects a common practice in the healthcare technology sector, and broader public markets, where companies use equity-based compensation to incentivize executives and align their long-term interests with those of shareholders. The election to convert a cash bonus into RSUs, particularly at an incentivized rate, is a strategic move to foster executive retention and commitment to company performance.
Comparison to Industry Standards
- Many publicly traded companies, including those in the healthcare technology space, utilize equity-based compensation such as Restricted Stock Units (RSUs) for senior executives to align management interests with shareholder value.
- The practice of offering an incentivized conversion rate (e.g., 115% of cash bonus into equity) is a common mechanism to encourage executives to hold company stock, demonstrating confidence and commitment, similar to practices observed at companies like Teladoc Health (TDOC) or Veeva Systems (VEEV) in their executive compensation structures.
Stakeholder Impact
- Shareholders: Increased insider ownership can be viewed positively as it aligns management's financial interests with those of other shareholders, potentially indicating confidence in long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 09/11/2025 | Date of transaction for the acquisition of Restricted Stock Units. |
| 09/15/2025 | Date the Form 4 was signed by Allison Hoffman as Attorney-in-Fact for Yvonne Hui. |
| 01/31/2026 | End of the fiscal year for which the cash bonus, converted into RSUs, was earned for the first half. |
Keywords
Phreesia, PHR, Yvonne Hui, Insider Transaction, Form 4, Restricted Stock Units, RSUs, Executive Compensation, Equity Award, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.